Navigation Links
Study Shows Machine Perfusion Significantly Improves Transplant Results
Date:12/31/2008

global medical technology company with European headquarters in Brussels. Organ Recovery Systems develops advanced perfusion techniques to improve the quality and quantity of organs, tissues and cells for transplantation. Working with a team of leading transplant professionals, Organ Recovery Systems develops medical devices, chemical solutions and techniques to improve the process by which cells, tissues and organs are treated -- from the time of donation to the time of transplantation.

Organ Recovery Systems initial product is the LifePort Kidney Transporter. During its pilot introduction phase, 270 LifePorts have perfused more than 12,000 kidneys in transplant programs worldwide. Medical devices for ex vivo preservation of the heart, lung, pancreas and liver are in pre-clinical development.


'/>"/>
SOURCE Organ Recovery Systems
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Nature Medicine study shows Peregrines bavituximab can cure lethal virus infections
2. New study indicates smallpox vaccination effective for decades
3. Cardiums InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study
4. Parion Sciences Receives NIH Biodefense Grant to Study Novel Methods for Mitigating Radiation-Induced Lung Injury
5. QRxPharma Initiates Comparative Study for MoxDuoIR(TM) Dual-Opioid(TM) Pain Therapy
6. Alimera Sciences Begins Pilot Study to Assess Safety and Efficacy of Iluvien(TM) in Patients With Bilateral Geographic Atrophy Due to AMD
7. Oncolytics Biotech Inc.s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study
8. NOVAVAX and the University of Massachusetts Medical School Announce Preclinical Study Results for a Respiratory Syncytial Virus (RSV) Vaccine Candidate
9. Nile Therapeutics Announces Positive Results from Phase 1b Safety and Pharmacodynamics Study of CD-NP in Patients with Heart Failure
10. Omeros Announces Results from a Phase 1 Study of OMS201 for Use During Urological Surgery
11. Cryoablation of Early Invasive Ductal Breast Cancer With MRI Confirmation Shows Promising Clinical Benefits, According to Study Presented at RSNA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... 15 Repligen Corporation (Nasdaq: RGEN ... $731,000 in research funding to support the ongoing ... the Muscular Dystrophy Association (MDA). This grant ... testing and GMP manufacture of a drug candidate ... MDA not only provides important funding for Repligen,s ...
(Date:12/15/2009)... Reportlinker.com announces that a new ... catalogue: ,, The Future of ... 2015, Pipeline Analysis and Reimbursement ... ,, Summary ,, The author ... of Orphan Diseases Therapeutics - Market Forecasts ...
(Date:12/15/2009)... Va., Dec. 15 AstraZeneca (NYSE: ... of Virginia (UVa) in Charlottesville, today announced ... research collaboration to enhance development of new ... with a secondary focus on peripheral vascular ... ) ,, The collaborative preclinical research projects ...
(Date:12/15/2009)... Company (NYSE: MOS ) plans to issue ... financial tables on Tuesday, January 5, 2010, after the ... Results will be available on Mosaic,s website at ... conference call with presentation slides on Wednesday, January 6, ... begin at 11:00 a.m. Eastern Standard Time (10:00 a.m. ...
Breaking Biology Technology:Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2
... Poole, an economic and community development specialist, presented a ... 2004 Governors Conference on Economic Development . Abstaining from ... keep and grow businesses in Wisconsin. , ,Wisconsin manufacturing ... breakdown, Poole said. He cited that Wisconsin saw only ...
... Wis. -- Bone Care International, Inc. announced Tuesday Herbert Conrad ... Mazess. Mazess will remain on the board of directors. ... the U.S. Pharmaceuticals Division of Hoffmann-La Roche, Inc. He served ... Inc. from 1996 to 2003, and was a co-founder of ...
... TeraMEDICA announced today Jim Prekop as president of ... from Peoplesoft where he recently served as ... to joining Peoplesoft, Prekop spent 14 years with Dun ... Hanna.said that the move will allow him to focus ...
Other Biology Technology:Optimistic Outlook For Manufacturing 2
(Date:12/15/2009)... treating devastating brain diseases such as Alzheimer,s and Parkinson,s, ... something to help a patient. , But they come ... majority of patients with ataxia disabling disorders that ... of Florida neurologists are trying to change that with ... the National Institute of Neurological Disorders and Stroke to ...
(Date:12/15/2009)... mammoths and ancient American horses may have been ... years longer than previously thought. After plucking ancient ... team of researchers used cutting-edge techniques to uncover ... samples dated to between 7,600 and 10,500 calendar ... one population of these now-extinct mammals endured longer ...
(Date:12/15/2009)... on society. It is estimated that 100 to 150 ... and it,s likely that rip currents account for more than ... rip current research and public understanding. Rip currents are ... most people do not know how to even identify, much ... the Rip Current Symposium is to identify advancements in rip ...
Breaking Biology News(10 mins):UF to lead national effort to help patients with rare brain disease 2UF to lead national effort to help patients with rare brain disease 3Late-surviving megafauna exposed by ancient DNA in frozen soil 2Late-surviving megafauna exposed by ancient DNA in frozen soil 3Late-surviving megafauna exposed by ancient DNA in frozen soil 4Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for Modified Dutch Auction Tender Offer to Purchase up to 2465 000 000 6103 1Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for Modified Dutch Auction Tender Offer to Purchase up to 2465 000 000 6103 2Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for Modified Dutch Auction Tender Offer to Purchase up to 2465 000 000 6103 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6101 1Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6101 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6101 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6101 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6101 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6101 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6101 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6101 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6101 9Obesity Seems to Alter Heart Structure 61019 1
... pressure has finally seen the price of antiretroviral therapy for ... simple diagnostics to enable doctors to use these complex treatments ... New York universities believe they have the solution: a hand-held ... in seconds. At the moment it can take a week ...
... Many, if not all, plants maintain relationships with bacteria, ... to get rid of freeloaders, University of California, Berkeley, ... coastal California lupine that harbors nitrogen-fixing bacteria in its ... respond differently to bacteria that efficiently produce nitrogen than ...
... infection is small in Australia and people can still safely eat ... Bob Doneley. , "The chances of getting bird flu off ... UQ School of Veterinary Science Adjunct Professor Dr Doneley said. ... a meteor and fall on your head than somebody getting bird ...
Other Biology News:Cheap, rapid hand-held check for HIV 2Plants, too, have ways to manage freeloaders 2Plants, too, have ways to manage freeloaders 3Plants, too, have ways to manage freeloaders 4Expert dispels bird flu paranoia 2
Hamster serum...
... CyScribe First-Strand cDNA Labeling System ... Kit, 50 reactions. For the generation ... cDNA.Optimized reagents are packaged together for ... optimized protocols can be used for ...
... First-Strand cDNA Labeling System - dUTP ... reactions. For the generation and purification ... are packaged together for complete cDNA ... can be used for performing labeling ...
... Quality ISO 9001:2000 Certified ... All Precedures Validated, SOP's Training ... Process for All Procedures GLP Documentation Upon ... one stop shopping point for all your ...
Biology Products: